The French company Flash Therapeutics, a specialist in the design and bioproduction of highly pure, highly concentrated DNA and RNA lentiviral solutions for the biopharmaceutical industry, has a new president. Jérôme Bédier (49), has extensive experience in the field of bioproduction and CDMO. He held positions in business development and operational management before taking over the strategic leadership of the Novartis biopharmaceutical business and its three European Locations. In 2021, Bedier joined Cell-Easy as Chief Operating Officer. There he was responsible for structuring and launching the CDMO's cell therapy activities.

"We are delighted to welcome Jérôme Bédier, an expert in biomanufacturing and service to the biopharmaceutical industry, to the executive management of Flash Therapeutics. His expertise in the design and production of biotherapeutic products, and his perfect knowledge of markets and customers will be a considerable asset in accelerating Flash Therapeutics' strategy in the biomanufacturing of DNA and RNA lentiviral solutions, by strengthening partnerships with the company's existing customer portfolio and developing new ones" said Jacques Rossignol, Chairman of Flash Therapeutics' Supervisory Board.